Declaration of Helsinki expert conference on the Ethics of placebo control in clinical trials- comments on the "reasonable availability" approach

Japan Medical Association Journal

Volumn 54, Issue 6, 2011, Pages 346-350

  Kuroyanagi, Tatsuo ^a   Ishii, Masami ^a  

^a World Medical Association   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ARTICLE; CLINICAL RESEARCH; CONTROLLED CLINICAL TRIAL (TOPIC); HUMAN; INFORMED CONSENT; JAPAN; MEDICAL ETHICS; MEDICAL SOCIETY; METHODOLOGY; PLACEBO EFFECT; PRACTICE GUIDELINE; RISK BENEFIT ANALYSIS; STANDARD; WORLD HEALTH ORGANIZATION;

EID: 84856818388     PISSN: 13468650     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. World Medical Association. WMA Declaration of Helsinki-Ethical Principles for Medical Research Involving Human Subjects. 2008. http://www.wma.net/en/30publications/10policies/b3/index. html. Accessed Sep 12, 2011.
2. CIOMS. Guideline 10: Research in populations and communities with limited resources. International Ethical Guidelines for Biomedical Research Involving Human Subjects. 2002.
3. Participants in the 2001 Conference on Ethical Aspects of Research in Developing Countries. Moral standards for research in developing countries: from "reasonable availability" to "fair benefits". Hasting Center Rep. 2004 May-Jun; 34(3):17-27.
4. Taupitz J. The New World Medical Association Declaration of Helsinki. WMJ. 2001;47(4):51-64.